MED

MEDIFAST INC

12.00 USD

Last updated Sep 12, 02:27 UTC

Yesterday HIGH

$12.08

Yesterday LOW

$11.88

52w HIGH

$14.67

52w LOW

$9.22

EPS

-0.28

PE

-42.86

Next Earnings

Nov 2, 2026

Overview News Unusual Options Flow Insider Transactions Government Trades Fundamentals

MEDIFAST INC stock is up 4.53% since 30 days ago. The next earnings date is Nov 2, 2026. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 37.5% of the previous 23 September’s closed higher than August. In the last 5 Unusual Options Trades, there were 5 CALLs.

Options Flow Last 10
Date & Time	Expiration Date	Strike Price	Trade Type	Size	Open Interest

22 Jul 16:14	21 Aug, 2026	7.50	CALL	200	0
22 Jul 16:26	21 Aug, 2026	7.50	CALL	200	0
22 Jul 19:05	20 Nov, 2026	10.00	CALL	300	4525
04 Aug 13:47	18 Sep, 2026	10.00	CALL	159	8168
03 Sep 15:16	18 Dec, 2026	10.00	CALL	100	1280

Advanced Data Unlock

Benzinga Newsdesk

Mon Aug 3, 2026

Medifast Sees Q3 GAAP EPS $(0.65)-$(0.15) vs $(0.62) Est; Sees Sales $60.000M-$80.000M vs $67.700M Est

Medifast (NYSE:MED) is looking for Q3 GAAP EPS of $(0.65)-$(0.15) vs $(0.62) analyst estimate. sees sales of $60.000 million-$80.000 million vs $67.700 million analyst estimate.
Benzinga Newsdesk

Mon Aug 3, 2026

Medifast Q2 Adj. EPS $(0.28) Beats $(0.65) Estimate, Sales $76.384M Beat $72.700M Estimate

Medifast (NYSE:MED) reported quarterly losses of $(0.28) per share which beat the analyst consensus estimate of $(0.65) by 56.92 percent. This is a 227.27 percent decrease over earnings of $0.22 per share from the same
Benzinga Newsdesk

Fri Jul 17, 2026

Medifast Launches Trilivy, Comprehensive Metabolic Health System; Co. Also Unveils Newly Formulated Meal Replacements, Including Trilivy Reset Fueling Line Enhanced With MetaVantage Technology

The leading health and wellness company unveils an evolutionary transformation from weight loss to optimal metabolic health, powered by breakthrough science and human connectionMedifast, Inc. (NYSE:MED) today announced
Benzinga Newsdesk

Tue May 26, 2026

MEDIFAST Appoints Nicholas Johnson As CEO Effective June 1
Benzinga Newsdesk

Tue May 5, 2026

Medifast shares are trading higher after the company reported better-than-expected Q1 financial results and reaffirmed its FY2026 EPS and FY2026 sales guidance.
Benzinga Newsdesk

Mon May 4, 2026

Medifast Affirms FY2026 GAAP EPS Guidance of $(2.75)-$(1.55) vs $(1.98) Est; Affirms FY2026 Sales Guidance of $270.000M-$300.000M vs $273.700M Est

Medifast (NYSE:MED) affirms FY2026 GAAP EPS guidance from $(2.75)-$(1.55) to $(2.75)-$(1.55) vs $(1.98) analyst estimate. Affirms FY2026 sales outlook from $270.000 million-$300.000 million to $270.000 million-$300.000
Benzinga Newsdesk

Mon May 4, 2026

Medifast Sees Q2 GAAP EPS $(1.00)-$(0.50) vs $(0.43) Est; Sees Sales $60.000M-$80.000M vs $74.700M Est

Medifast (NYSE:MED) is looking for Q2 GAAP EPS of $(1.00)-$(0.50) vs $(0.43) analyst estimate. sees sales of $60.000 million-$80.000 million vs $74.700 million analyst estimate.
Benzinga Newsdesk

Mon May 4, 2026

Medifast Q1 EPS $(0.19) Beats $(0.52) Estimate, Sales $76.044M Beat $69.200M Estimate

Medifast (NYSE:MED) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.52) by 63.46 percent. This is a 171.43 percent decrease over losses of $(0.07) per share from the same
Benzinga Insights

Mon May 4, 2026

Earnings Scheduled For May 4, 2026
Benzinga Insights

Wed Apr 29, 2026

12 Consumer Staples Stocks Moving In Wednesday's After-Market Session

Parsa Kiai, Director

Wed Aug 26, 2026

MED Recent Insider Trades and Stock Chart

43,150 shares bought
Parsa Kiai, Director

Mon Aug 24, 2026

MED Recent Insider Trades and Stock Chart

4,329 shares bought
Parsa Kiai, Director

Wed Aug 19, 2026

MED Recent Insider Trades and Stock Chart

29,337 shares bought
Parsa Kiai, Director

Thu Aug 20, 2026

MED Recent Insider Trades and Stock Chart

43,150 shares bought